Tag Archives: BIO CEO & Investor Conference

BIO CEO & Investor Conference Closes with Record Breaking Partnering Numbers

bio-ceo-2016

The 18th Annual BIO CEO & Investor Conference, the largest investor conference focused on established and emerging publicly traded and select private biotech companies, took place this earlier this week in New York City at the Waldorf Astoria with more than 1,400 registrants, including over 600 registered investors. The event featured 9 educational program sessions, including business roundtables, therapeutic workshops and plenary sessions, 6 fireside chats with biopharma CEOs as well as a special guest, New York Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Session Recap: Advances in Ophthalmology: Therapies for Saving Sight

ophthalmology panel at BIO CEO & Investor Conference

Monday at the BIO CEO & Investor Conference featured a 9:30am panel that offered a comprehensive perspective on what is happening in the world of ophthalmology today.  The panel was moderated by Tony Gibney, Managing Director, Leerink Partners. The panelists were: Jeffrey L. Cleland, PhD, Interim Chief Executive Officer, GrayBug Guy Eakins, PhD, Vice President, Scientific Affairs, BrightFocus Foundation Nouhad Husseini, Vice President, Business Development, Regeneron David P. Southwell, President and Chief Executive Officer, Inotek Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Announcing the BIO/Bloomberg Intelligence: 2016 Biotech Industry Outlook Survey

BIO CEO and Investor Conference

BIO, in conjunction with Bloomberg Intelligence, invites you to answer a brief, 3-minute, industry outlook survey. Please share your expertise to tap into the “wisdom of the crowd.” Answer our 16 questions to get your 2016 answers. Survey participants will get first access to results before the rest of the biotech community. All responses will remain anonymous. Where do your forecasts fit among your colleagues’ estimates? What research developments are they watching most closely? Click Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Vote for the Buzz of BIO at the 2016 BIO CEO & Investor Conference

buzz-of-bio-logo

Voting is now open! See the 20 nominees and cast your vote once per day in the Buzz of BIO contest. Don’t forget to register for the BIO CEO & Investor Conference; early bird discounts end December 17. Ten biotechs were nominated in two categories, “Most Buzzworthy Public Company” and “Most Buzzworthy Private Company.” To qualify for the Most Buzzworthy Public Company Grand Prize, companies must be publicly traded and headquartered in the United States. To qualify for Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Be the Buzz of BIO at the 2016 BIO CEO and Investor Conference

Buzz of BIO contest, BIO Investor Forum

The nomination period is underway for the Buzz of BIO content at the 2016 CEO & Investor Conference! Each winner will receive a complimentary registration and presentation in the corresponding presentation track, and have the opportunity to impress investors with their company’s latest developments. The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, we present Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,